PrEP Use Doubles Over 3 Years, but Uneven Access Persists
Despite an improved HIV PrEP-to-need ratio from 2018 to 2021, PrEP use relative to need was lower in certain populations, including women and younger people.
Read MoreFeb 13, 2025
Despite an improved HIV PrEP-to-need ratio from 2018 to 2021, PrEP use relative to need was lower in certain populations, including women and younger people.
Read MoreFeb 2, 2025
Peer-led interventions for improving HIV prevention among Latino MSM exist, but research is needed before they can be fully implemented and used effectively.
Read MoreJan 31, 2025
A low-threshold, harm reduction-oriented program for PrEP would support initiation and continuation for homeless-experienced people who use drugs.
Read MoreJan 31, 2025
Study results indicate the need for multiple care and formulation choices to improve PrEP uptake among men who have sex with men.
Read MoreJan 13, 2025
A recent study shows an increasing number of US veterans are being prescribed PrEP, similar to trends among persons with commercial or public health insurance.
Read MoreJan 12, 2025
Research shows particularly low PrEP acceptance among women and people of non-White origin, as well as low acceptance among individuals diagnosed with an STI.
Read MoreJan 9, 2025
Among people who inject drugs (PWID), decisions around PrEP are impeded by more pressing needs, and focusing on autonomy may help to engage PWID in PrEP uptake.
Read MoreDec 25, 2024
Clinician-reported barriers to PrEP prescribing include finances, perceptions about HIV risk, lack of training, and the amount of time required for PrEP care.
Read MoreDec 24, 2024
Researchers found a steep increase in even-driven PrEP use among cisgender gay, bisexual, and other men who have sex with men.
Read MoreDec 23, 2024
About 3.5 million persons used PrEP in 2023 globally, which was far below the goal of 21.2 million set for 2025.
Read MoreDec 21, 2024
A peer-to-peer program successfully trained and mobilized volunteers to distribute information about PrEP to people not often included in outreach campaigns.
Read MoreDec 5, 2024
The mortality risk in patients with pre-existing auto-immune disease is not significantly different from those without AIDS, in an immune checkpoint inhibitor study.
Read MoreNov 27, 2024
Research shows many transgender women in the U.S. express interest in long-acting injectable PrEP but face barriers to accessing preventive treatment.
Read MoreNov 14, 2024
In general, many people who inject drugs perceive themselves to be at a low risk for HIV despite having indications for pre-exposure prophylaxis use.
Read MoreNov 13, 2024
The annual number of PrEP users increased in the United States from 10,281 in 2013 to 505,730 in 2023, primarily in oral formulations.
Read MoreNov 12, 2024
In a study of PrEP use in Black sexual minority men, PrEP stigma was associated with a lower likelihood of current PrEP use in all models examined.
Read MoreOct 25, 2024
Researchers discuss efforts to improve PrEP access in transgender and other transmasculine men who are under-represented in research and prevention efforts.
Read MoreOct 24, 2024
A PrEP program that included medication distribution and counseling could reduce thousands of new cases of HIV and gonorrhea and showed potential for scaling.
Read MoreOct 23, 2024
Testosterone, Lactobacillus, and lower PrEP medication concentrations in cervicovaginal fluid may impact HIV risk in transgender men.
Read MoreSep 30, 2024
A recent literature review highlighted “complex intersections” between intimate partner violence and PrEP care engagement among sexual minority men.
Read More